As of May 2026 Cadrenal Therapeutics has a market cap of A$21.24 Million. This makes Cadrenal Therapeutics the world's 10402th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 29th, 2026 the market cap of Cadrenal Therapeutics was reported to be: